RS
GILD icon

Rakuten Securities’s Gilead Sciences GILD Stock Holding History

Rakuten Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32K Buy
50
+13
+35% +$1.71K ﹤0.01% 529
2026
Q1 		$5.16K Sell
37
-71
-66% -$9.94K ﹤0.01% 508
2025
Q4 		$13.3K Buy
108
+50
+86% +$6.08K ﹤0.01% 397
2025
Q3 		$6.44K Sell
58
-413
-88% -$46.9K ﹤0.01% 474
2025
Q2 		$52.2K Sell
471
-188
-29% -$20K 0.02% 219
2025
Q1 		$73.8K Buy
659
+635
+2,646% +$65.5K 0.04% 177
2024
Q4 		$2.22K Sell
24
-721
-97% -$64.9K ﹤0.01% 554
2024
Q3 		$62.5K Sell
745
-270
-27% -$20.6K 0.03% 172
2024
Q2 		$69.6K Buy
1,015
+328
+48% +$21.9K 0.03% 153
2024
Q1 		$50.3K Buy
687
+277
+68% +$21.3K 0.02% 185
2023
Q4 		$33.2K Buy
+410
New +$31.9K 0.03% 189

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rakuten Securities's GILD Position: Q2 2026 in Review

Rakuten Securities increased its Gilead Sciences (GILD) stake by 35% in Q2 2026, buying an estimated $1.71K and bringing the position to 50 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #529.

Rakuten Securities first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $73.8K in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Rakuten Securities held 50 shares of Gilead Sciences worth $6.32K as of Q2 2026.
  • Rakuten Securities bought 13 Gilead Sciences shares in Q2 2026, an estimated $1.71K.
  • Gilead Sciences made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #529 holding.
  • Rakuten Securities first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Gilead Sciences position peaked at $73.8K in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.